Comments
Pharma major Zydus Cadila informed that the company has received the final approval from the US drug regulator to market Clonidine Hcl Injections. As per the announcement made by the company, the US Food and Drug Administration (USFDA) has given approval “to market Clonidine Hcl Injection 0.1 and 0.5 mg/ml, 10 ml.” Clonidine hydrochloride injection is a centrally acting analgesic solution for use in continuous epidural infusion devices which is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not relieved by opioid analgesics alone, the company statement said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.